Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Chugai Pharmaceutical Co Ltd banner

Chugai Pharmaceutical Co Ltd
OTC:CHGCF

Watchlist Manager
Chugai Pharmaceutical Co Ltd Logo
Chugai Pharmaceutical Co Ltd
OTC:CHGCF
Watchlist
Price: 39.8525 USD -3.68% Market Closed
Market Cap: $65.6B
Write Note Create Alert Ask AI

Wall St Price Targets

CHGCF Price Targets Summary
Chugai Pharmaceutical Co Ltd

Wall Street analysts forecast CHGCF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CHGCF is 58.8665 USD with a low forecast of 44.5005 USD and a high forecast of 86.6615 USD.

CHGCF Lowest Forecast
Wall Street Target
$44.5005
12% Upside
CHGCF Average Forecast
Wall Street Target
$58.8665
48% Upside
CHGCF Highest Forecast
Wall Street Target
$86.6615
117% Upside
Lowest Forecast
Price Target
44.5005 USD
12% Upside
Average Forecast
Price Target
58.8665 USD
48% Upside
Highest Forecast
Price Target
86.6615 USD
117% Upside
Chugai Pharmaceutical Co Ltd Competitors:
Price Targets

Revenue
Forecast

10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 10%.

What are analyst estimates?

Gross Profit
Forecast

12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 11%.

What are analyst estimates?

Operating Income
Forecast

18% / Year
Past Growth
-15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
18% / Year
Past Growth
-15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 12 years is -15%.

What are analyst estimates?

Pre-Tax Income
Forecast

18% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
18% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 15%.

What are analyst estimates?

Net Income
Forecast

19% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
19% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 15%.

What are analyst estimates?

Continue CHGCF Research

Summary
CHGCF intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHGCF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHGCF stock valuation using valuation multiples.
Wall St Estimates
CHGCF price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHGCF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Chugai Pharmaceutical Co Ltd listings:
OTC • USD
CHGCY
 F • EUR
CUP
 XBER • EUR
CUP
 TSE • JPY
4519
 XMUN • EUR
CUP
 SWB • EUR
CUP
 DUS • EUR
CUP
 F • EUR
CUP0
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CHGCF's stock price target?
Price Target
58.8665 USD

According to Wall Street analysts, the average 1-year price target for CHGCF is 58.8665 USD with a low forecast of 44.5005 USD and a high forecast of 86.6615 USD.

What is the Revenue forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 10%.

What is the Gross Profit forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
-15%

Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 12 years is -15%.

What is the Pre-Tax Income forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett